SurgePays Inc stock (US87957J1079): Q4 2025 loss and short-interest shift keep Nasdaq focus on SURG
01.06.2026 - 18:21:34 | ad-hoc-news.deSurgePays Inc shares on the Nasdaq Capital Market continue to attract attention in the United States after the company reported its Q4 2025 results on 05/20/2026 and short-interest data through mid-May 2026 showed a moderation in bearish positioning.
According to MarketBeat, SurgePays posted Q4 2025 earnings per share of -USD 0.51 on 05/20/2026, compared with a consensus expectation of -USD 0.19, underscoring ongoing losses as the company invests in its fintech and telecom platform for underbanked customers in the United States.
While SurgePays has not yet confirmed the exact date of its next quarterly earnings release, MarketBeat estimates that the following report could fall around mid-August 2026, based on the timing of its prior-year disclosures.
More recently, short-interest statistics compiled by MarketBeat indicate that as of 05/15/2026 SurgePays had 571,142 shares sold short, equivalent to roughly 3.21% of the public float, compared with 919,196 shares or about 5.16% of float as of 04/30/2026, suggesting that some bearish positions were covered into the second half of May 2026.
MarketBeat also reports that the short-interest ratio for SurgePays stood near 1.0 days to cover based on average trading volume of 376,236 shares as of late April 2026, a level that typically points to manageable short-covering pressure on a US small-cap stock.
On the home US market, SurgePays is listed on Nasdaq under the ticker SURG, giving American investors access to the stock in US dollars within the broader US small-cap technology and telecom ecosystem.
For German-speaking investors who follow US small caps, SurgePays is also available on German trading venues such as Tradegate via secondary listings, enabling trading in euros alongside the companys primary US listing.
The stock price on Nasdaq fluctuates with daily trading conditions, and investors in the United States track the SURG quote in real time through market data services and broker platforms that aggregate bids, offers, and last-trade information throughout the US trading session.
As of: 01.06.2026
By the editorial team - specialized in equity coverage.
At a glance
- Name: SurgePays Inc
- Sector/industry: Financial technology and telecommunications services
- Headquarters/country: Bartlett, United States
- Core markets: Underserved and underbanked consumers across the United States
- Key revenue drivers: Prepaid wireless services, fintech products, and transactional services via a retailer network
- Home exchange/listing venue: Nasdaq Capital Market (SURG)
- Trading currency: USD
SurgePays Inc: core business model
SurgePays positions itself as a US-based fintech and telecom platform that connects underbanked consumers with prepaid wireless, financial, and transactional services through a network of independent retailers.
What banks and research houses say about SurgePays Inc
No verified analyst coverage was identified at the time of publication.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Sentiment and reactions on SurgePays Inc
Following the Q4 2025 loss and changes in short interest, social media and video platforms feature ongoing debate among retail traders about the prospects for SurgePays in the US small-cap fintech and telecom space.
Conclusion
The latest Q4 2025 figures leave SurgePays still in loss-making territory, but the decline in short interest into mid-May 2026 points to some investors reassessing their most negative views on the stock.
With no clearly documented analyst coverage from major US banks at this stage, the story around SurgePays remains driven largely by company disclosures, trading data, and sentiment among US retail investors rather than by formal research coverage.
How the company balances growth initiatives in fintech and telecom with a path toward profitability will be central to how the Nasdaq market ultimately values SurgePays over coming quarters.
Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.
So schätzen die Börsenprofis SURG Aktien ein!
Für. Immer. Kostenlos.
